Pictet Asset Management Holding Sa Cerevel Therapeutics Holdings, Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 9,563 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,563
Previous 9,563
-0.0%
Holding current value
$0
Previous $404,000
3.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CERE
# of Institutions
227Shares Held
153MCall Options Held
2.19MPut Options Held
3.84M-
Bain Capital Investors LLC Boston, MA65.7MShares$065.37% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.54MShares$04.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.15MShares$00.01% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...